Objective: To analyze the expression profile variation of lncRNAs in normal urinary bladder
tissue and urothelial carcinoma of the urinary bladder through microarray technology. The …

Objective HER-2 is overexpressed in a variety of human malignant tumors and has been
widely used in the prognosis and treatment of breast cancer. In urothelial cell carcinoma of …

The study analyzes the immunoexpression of EGFR and Her2/neu in 45 cases of papillary
urothelial bladder carcinoma. The cases have been investigated through histopathological …

Bladder cancer is one of the most common cancers in the United States. Numerous markers
have been evaluated for suitability of bladder cancer detection and surveillance. However …

Aims The purpose of this study was to determine if any relationship exists between
expression of COX2 and iNOS markers and urinary schistosomiasis in bladder cancers …

Introduction: Urothelial carcinoma poses a great challenge in disease management due to
the high recurrence rate and a greater likelihood of disease progression. HER2 (human …

Background: Urothelial carcinoma (UC) is an aggressive tumor with high recurrence rates
and poses a great challenge for clinical management. Programmed death ligand-1 (PD-L1) …

Urinary bladder cancer is the 9th most common type of cancer and the 13th most common
cause of death worldwide. C-erbB-4 is a class of oncogenes plays a role in cancer …

Background: Bladder cancer is one of the commonest malignancies among Egyptian
population with high morbidity and mortality rates. Human epidermal growth factor receptor …

Background: A variety of biomarkers have been used to assess the prognosis of urinary
bladder neoplasm (UBN). In the present study role of two novel biomarkers (HER2/neu and …